Journal
← Tickers

JNJ

JNJ — Ruslan Averin's Analysis · 2 entries

  1. Johnson & Johnson (JNJ) Q3 2026 Results: EPS $2.59 vs $2.53 Expected, Sales $25.4B, 2026 Guidance Raised to $11.10
    ·7 min read

    Johnson & Johnson (JNJ) Q3 2026 Results: EPS $2.59 vs $2.53 Expected, Sales $25.4B, 2026 Guidance Raised to $11.10

    Johnson & Johnson Q3 2026 results: adjusted EPS $2.59 vs $2.53, sales $25.40B in line, MedTech +2.5%, Stelara -54.4%, 2026 EPS guide raised to $11.10.

  2. How I Generate Monthly Income with Covered Calls: My System on Dividend Stocks
    ·8 min read

    How I Generate Monthly Income with Covered Calls: My System on Dividend Stocks

    I sell covered calls on 4 dividend stocks — JNJ, PG, KO, XOM — generating 1.14%/month on top of dividends. My exact selection criteria and setup.